| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00192638 |
| P698 | PubMed publication ID | 7757287 |
| P2093 | author name string | J Hurlimann | |
| B Larrinaga | |||
| D L Vala | |||
| P2860 | cites work | Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes | Q24317668 |
| Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years | Q24680218 | ||
| Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells | Q28294137 | ||
| Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death | Q29620000 | ||
| Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 | Q29622924 | ||
| Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections | Q33263235 | ||
| Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation | Q34559025 | ||
| Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma | Q35617276 | ||
| Bcl-2 initiates a new category of oncogenes: regulators of cell death | Q35675178 | ||
| Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. | Q35833088 | ||
| Programmed cell death: apoptosis and oncogenesis. | Q36399233 | ||
| The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation | Q36766445 | ||
| BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death | Q37572590 | ||
| The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction | Q37974995 | ||
| Down-regulation of bcl-2 by p53 in breast cancer cells. | Q41473714 | ||
| Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation | Q41957968 | ||
| bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation | Q41964290 | ||
| Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer | Q42457244 | ||
| bcl-2 protein in non-small-cell lung carcinoma | Q42508274 | ||
| The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining | Q48375088 | ||
| Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. | Q48377324 | ||
| Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. | Q54251768 | ||
| Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast | Q59289514 | ||
| Ultrastructural observations on cell death by apoptosis in the ?resting? human breast | Q61703994 | ||
| Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues | Q67594938 | ||
| Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms | Q67939380 | ||
| Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma | Q68226386 | ||
| Inhibition of radiation-induced apoptosis in vitro by tumor promoters | Q68501075 | ||
| Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation | Q68821821 | ||
| A correlative morphologic study of human breast and endometrium in the menstrual cycle | Q69536131 | ||
| The bcl-2 gene is rearranged in many diffuse B-cell lymphomas | Q70050957 | ||
| The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes | Q70136807 | ||
| Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma | Q70567786 | ||
| Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas | Q72567682 | ||
| Prognostic value of p53 protein expression in breast carcinomas | Q72760415 | ||
| An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease | Q72809577 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 163-168 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Virchows Archiv | Q19059548 |
| P1476 | title | bcl-2 protein in invasive ductal breast carcinomas | |
| P478 | volume | 426 |
| Q77763768 | Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells |
| Q73928775 | Analysis of bcl-2 in sporadic breast carcinoma |
| Q77371073 | Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry |
| Q41176259 | Apoptosis: pathophysiology of programmed cell death |
| Q60044026 | BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score |
| Q36116339 | Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas. |
| Q41822088 | Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma |
| Q36621098 | Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women |
| Q73369589 | Cytological evaluation of biological prognostic markers from primary breast carcinomas |
| Q43871133 | Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. |
| Q73707441 | Expression of Bcl-2 protein in human primary breast carcinomas and its correlation with multifocality, histopathological types and prognosis |
| Q73224728 | Expression of bcl-2 Protein in Breast Carcinoma with Correlation to Expression of p53 Protein and Clinicopathological Factors |
| Q24797919 | Gene therapy for carcinoma of the breast: Pro-apoptotic gene therapy |
| Q78036365 | Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia |
| Q74720116 | Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis |
| Q73082873 | Immunohistochemical localization of Bcl-2 and Bax proteins in in situ and invasive duct breast carcinomas |
| Q74226141 | Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2 |
| Q73539039 | Prognostic significance of Bcl-2 and p53 expression in gastric cancer |
| Q58136330 | Quantitation of erbB2 positivity for evaluation of high-risk patients |
| Q78238122 | Regulators of apoptosis in human breast cancer |
| Q34002800 | The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2. |
| Q35355084 | The pathology of hereditary breast cancer |
Search more.